
Overview
Medigen is a medical entity that specializes in selecting the best bone marrow donors and conducting complex diagnostic tests for patients with leukemia and other hematological diseases. It provides comprehensive support for patients and their families, addressing various issues they encounter. Medigen is also the only laboratory in the country with all necessary certifications to ensure the highest quality of its services in the European Union and beyond.
Financials
Revenue history (in k)
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 308 days for 2020).
- 202523/07/2026
- 202415/07/2025
- 202321/08/2024
- 202218/07/2023
- 202111/08/2022
- 202019/08/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Bone marrow donor matching
- HLA antigen typing
- Bone marrow donor search
- Genetic testing
- Oncohematology care
Websites
- medigen.plMedigen Sp. z o.o. – podmiot leczniczy – dobieramy najlepszych dawców szpikuWordPress 1.10Nginx
Public procurement
1 tender recorded as contractor.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Aug 16, 2024 | Call for tenders for the provision of healthcare services | –– | Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy |
National Health Fund (NFZ) contracts
The company has been an NFZ healthcare provider since 2008. In 2026 it is performing 1 contract worth USD 50.63k. All its contracts were worth USD 958.73k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Separately contracted healthcare services | mazowieckie | 1 | USD 50.63k |
Trademarks
The company currently holds no active trademarks with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 1998.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| Mark without a word element (figurative) | Z.311435 | 44 | Expired | – | |
| medigen (word) | Z.191896 | 0, 42 | Expired | – |
| Mark | Protected until | |
|---|---|---|
| Mark without a word element (figurative) | – | |
| medigen (word) | – |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to submit declarations of will on behalf of the company. In the case of a one-person management board, a member of the management board acting independently is authorized to submit declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Jadwiga Sankowska age 64 | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medismart sp. z o.o. | 133,711.51 USD | 99% |
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2003-10-22.
91 1440 1299 0000 0000 1450 2068
15 1050 1025 1000 0022 7301 8958
85 1050 1025 1000 0022 7598 9875
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $40,579.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 17, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $692$692 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,484$4,484 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $4,806$4,806 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2017-02-09 | Purchase of R&D services for methods of statistical analysis of HLA genotype matching results (level II) in the studied population of samples from European donors and recipients, as well as support for developing a prototype mechanism for an IT module for statistical validation concerning the analysis and selection of donors based on genetic mismatch from level 7/10 in the laboratory genetic testing and results process. | $26,100$26,100 | Regional Operational Programme for the Mazowieckie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Warsaw Genomics sp. z o.o. | $1,712,726.96 | warsawgenomics.pl | ||
| Masdiag sp. z o.o. | $1,691,863.39 | masdiag.pl | ||
| Centrum Medyczne Marki sp. z o.o. | $1,184,620.85 | cmmarki.pl | ||
| Przebadani.Pl sp. z o.o. | $978,333.25 | przebadani.pl | ||
| Longevity Plus sp. z o.o. | $866,093.85 | longevityplus.pl | ||
| Euromed Lab sp. z o.o. | $626,318.43 | euromedlab.pl | ||
| CD Słodczyk sp. z o.o. | $550,405.39 | cdlab.com.pl | ||
| Swiss-Lab sp. z o.o. | $394,867.25 | swisslab.pl | ||
| Amimed sp. z o.o. | $374,588.08 | amimed.pl | ||
| Centrum Zdrowia Panaceum sp. z o.o. | $266,423.42 | panaceum-waw.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-09-06 | Address change (Ul. Kościelna 63, 05-135, Wieliszew → Ul. Kościelna 61, 05-135, Wieliszew) | |
| 2024-05-23 | Address change (Morcinka 5/19/21, 01-496, Warszawa → Ul. Kościelna 63, 05-135, Wieliszew) | |
| 2020-11-26 | PKD change (Removed: 72 codes; Added: 2 codes) | |
| 2013-11-25 | PKD change (Removed: 3 codes; Added: 75 codes) | |
| 2012-03-26 | Switch to PKD 2007 (8 PKD 1997 codes → 6 PKD 2007 codes) |
FAQ
Last updated: 2026-10-07